Rural Health
Resources by Topic: Healthcare needs and services
Medicare Fee-For-Service Beneficiaries with Opioid Use Disorder in 2018: Disparities in Prevalence by Beneficiary Characteristics
Examines the sociodemographic, Medicare eligibility, clinical, and geographic characteristics of Medicare beneficiaries with opioid use disorder (OUD). Identifies disparities in OUD prevalence among Medicare beneficiaries. Discusses opportunities to tailor policies and interventions to beneficiary groups with high OUD prevalence to ensure access to treatment.
Date: 12/2020
Sponsoring organization: Centers for Medicare & Medicaid Services
view details
Examines the sociodemographic, Medicare eligibility, clinical, and geographic characteristics of Medicare beneficiaries with opioid use disorder (OUD). Identifies disparities in OUD prevalence among Medicare beneficiaries. Discusses opportunities to tailor policies and interventions to beneficiary groups with high OUD prevalence to ensure access to treatment.
Date: 12/2020
Sponsoring organization: Centers for Medicare & Medicaid Services
view details
Montana Chronic Disease Prevention & Health Promotion Bureau: June 2018-July 2020 Progress Report
Report highlights the public health efforts in the areas of tobacco cessation, diabetes and cancer reduction, and promoting physical activity, among other issues in Montana. Compares rates over a two year span and details the programs designed to address them.
Date: 12/2020
Sponsoring organization: Montana Department of Public Health and Human Services
view details
Report highlights the public health efforts in the areas of tobacco cessation, diabetes and cancer reduction, and promoting physical activity, among other issues in Montana. Compares rates over a two year span and details the programs designed to address them.
Date: 12/2020
Sponsoring organization: Montana Department of Public Health and Human Services
view details
Factors That Might Affect SARS-CoV-2 Transmission Among Foreign-Born and U.S.-Born Poultry Facility Workers — Maryland, May 2020
Looks at workplace-related, community, and household factors that might affect person-to-person SARS-CoV-2 transmission, with data for U.S.- and foreign-born workers at two Maryland poultry processing facilities.
Author(s): Beth L. Rubenstein, Stefanie Campbell, Alysha R. Meyers, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 69(50), 1906-1910
Date: 12/2020
Sponsoring organization: Centers for Disease Control and Prevention
view details
Looks at workplace-related, community, and household factors that might affect person-to-person SARS-CoV-2 transmission, with data for U.S.- and foreign-born workers at two Maryland poultry processing facilities.
Author(s): Beth L. Rubenstein, Stefanie Campbell, Alysha R. Meyers, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 69(50), 1906-1910
Date: 12/2020
Sponsoring organization: Centers for Disease Control and Prevention
view details
Opioids in Medicaid: Concerns About Opioid Use Among Beneficiaries in Six Appalachian States in 2018
Examines the rates of opioid use of Medicaid beneficiaries in 6 Appalachian states in 2018. Discusses the amount of the prescriptions issued, the amounts of opioids received, and the amount of providers with questionable prescribing practices, among other opioid-related measures.
Date: 12/2020
Sponsoring organization: Office of Inspector General (HHS)
view details
Examines the rates of opioid use of Medicaid beneficiaries in 6 Appalachian states in 2018. Discusses the amount of the prescriptions issued, the amounts of opioids received, and the amount of providers with questionable prescribing practices, among other opioid-related measures.
Date: 12/2020
Sponsoring organization: Office of Inspector General (HHS)
view details
Few Patients Received High Amounts of Opioids from IHS-Run Pharmacies
Presents an evaluation of the opioid prescribing practices of the Indian Health Service (IHS). Bases analysis on IHS opioid prescribing data, discusses the role of electronic health records (EHRs) in monitoring opioid prescriptions, and makes recommendations to improve monitoring.
Date: 12/2020
Sponsoring organization: Office of Inspector General (HHS)
view details
Presents an evaluation of the opioid prescribing practices of the Indian Health Service (IHS). Bases analysis on IHS opioid prescribing data, discusses the role of electronic health records (EHRs) in monitoring opioid prescriptions, and makes recommendations to improve monitoring.
Date: 12/2020
Sponsoring organization: Office of Inspector General (HHS)
view details
Incidence of Adverse Events in Indian Health Service Hospitals
Explores the occurrence of harm events in Indian Health Service (IHS) hospitals. Discusses the rates of adverse harm events, or those leading to prolonged or permanent patient harm, and temporary harm events. Breaks down data by hospital size and patient age and reason for admission. Makes recommendations regarding quality control and oversight.
Date: 12/2020
Sponsoring organization: Office of Inspector General (HHS)
view details
Explores the occurrence of harm events in Indian Health Service (IHS) hospitals. Discusses the rates of adverse harm events, or those leading to prolonged or permanent patient harm, and temporary harm events. Breaks down data by hospital size and patient age and reason for admission. Makes recommendations regarding quality control and oversight.
Date: 12/2020
Sponsoring organization: Office of Inspector General (HHS)
view details
Instances of IHS Labor and Delivery Care Not Following National Clinical Guidelines or Best Practices
Evaluates the labor and delivery practices of Indian Health Service (IHS) hospitals and highlights instances when they deviate from national clinical guidelines. Discusses the negative patient outcomes from deviating from national guidelines and makes recommendations regarding site visits and training.
Date: 12/2020
Sponsoring organization: Office of Inspector General (HHS)
view details
Evaluates the labor and delivery practices of Indian Health Service (IHS) hospitals and highlights instances when they deviate from national clinical guidelines. Discusses the negative patient outcomes from deviating from national guidelines and makes recommendations regarding site visits and training.
Date: 12/2020
Sponsoring organization: Office of Inspector General (HHS)
view details
Emergency Department Visits Involving Influenza and Influenza-Like Illnesses, 2016–2018
Presents statistics on influenza-like illness (ILI)-related emergency department (ED) visits in 34 states and the District of Columbia from 2016 through 2018. Includes data by location of patient's residence for metropolitan, rural metropolitan-adjacent, and rural remote areas, as well as a state-by-state map indicating the patient residence location where the rate of ED visits was highest.
Author(s): Lawrence D. Reid, Kathryn R. Fingar
Date: 12/2020
Sponsoring organization: Agency for Healthcare Research and Quality
view details
Presents statistics on influenza-like illness (ILI)-related emergency department (ED) visits in 34 states and the District of Columbia from 2016 through 2018. Includes data by location of patient's residence for metropolitan, rural metropolitan-adjacent, and rural remote areas, as well as a state-by-state map indicating the patient residence location where the rate of ED visits was highest.
Author(s): Lawrence D. Reid, Kathryn R. Fingar
Date: 12/2020
Sponsoring organization: Agency for Healthcare Research and Quality
view details
Drug Pricing Program: HHS Uses Multiple Mechanisms to Help Ensure Compliance with 340B Requirements
Examines the Health Services and Research Administration's (HRSA) oversight of covered entities' compliance with 340B Program requirements. Describes the 340B Program, the HRSA audit process, and findings from audits conducted between 2012-2019. Discusses additional efforts by HRSA to promote compliance and identify noncompliance.
Additional links: Full Report
Date: 12/2020
Sponsoring organization: Government Accountability Office
view details
Examines the Health Services and Research Administration's (HRSA) oversight of covered entities' compliance with 340B Program requirements. Describes the 340B Program, the HRSA audit process, and findings from audits conducted between 2012-2019. Discusses additional efforts by HRSA to promote compliance and identify noncompliance.
Additional links: Full Report
Date: 12/2020
Sponsoring organization: Government Accountability Office
view details
Substance Use Disorder: Reliable Data Needed for Substance Abuse Prevention and Treatment Block Grant Program
Reviews what is known about the number of substance use disorder (SUD) treatment facilities and services, overall treatment capacity, and barriers to expanding capacity. Describes the Substance Abuse Prevention and Treatment Block Grant (SABG), State Targeted Response to the Opioid Crisis (STR) and State Opioid Response (SOR) programs, and examines how seven states utilized these programs. Evaluates the data used to assess the effectiveness of these programs, and offers recommendations to improve the reliability of data collected on individuals served by the SABG program.
Additional links: Full Report
Date: 12/2020
Sponsoring organization: Government Accountability Office
view details
Reviews what is known about the number of substance use disorder (SUD) treatment facilities and services, overall treatment capacity, and barriers to expanding capacity. Describes the Substance Abuse Prevention and Treatment Block Grant (SABG), State Targeted Response to the Opioid Crisis (STR) and State Opioid Response (SOR) programs, and examines how seven states utilized these programs. Evaluates the data used to assess the effectiveness of these programs, and offers recommendations to improve the reliability of data collected on individuals served by the SABG program.
Additional links: Full Report
Date: 12/2020
Sponsoring organization: Government Accountability Office
view details